Keynote Speakers for 2019
TIDES Offers the Science, Technologies and Partners You Need to Grow Your Business
1000+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
125+ CASE STUDIES AND NEW DATA PRESENTATIONS
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
90+ EXHIBITORS
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.
Webinar and Live Q&A
Join us Thursday, March 14, for the webinar "Evolution of Specifications and Analytical Methods During Synthetic Peptide Drug Development", being led by Dr. Michael Verlander of United States Pharmacopeia.
This webinar will cover the challenges, future opportunities, and best practices for characterizing and controlling the quality of synthetic peptides during development and release.
Present a scientific poster at TIDES 2019
Highlight your company's research by presenting a scientific poster at TIDES 2019. All posters will be displayed inside the exhibition throughout the duration of the conference.
To reserve your poster space, you must select the poster presentation option during your conference registration and submit your poster abstract at the link below by April 20, 2019. All poster submissions are reviewed by the TIDES advisory committee.
TIDES Tube - Watch Past Keynote Presentations
TIDES Tube provides the global oligonucleotide and peptide community with exclusive video content designed to help accelerate promising therapeutics from early discovery to late-stage development & commercialization.
Check out TIDES Tube now to watch video of last year's keynote presentations.
Do you want to highlight your company's expertise in TIDES Tube? Contact us today!
cross-fertilize ideas and best practices with researchers from different disciplines
TIDES offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical and CMC to late-stage development and commercialization.
Oligonucleotide Tracks
- Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
- Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Tracks
- Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
- Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
Connect with Key Buyers at TIDES 2019 in San Diego
Whether you're increasing your company profile, launching a new product or creating business development opportunities, we have flexible and tailored solutions that will optimize your investment. Contact our team today to see a list of pricing and package options:
Michael Moriarty
T: 1-646-895-7412
E: Michael.Moriarty@knect365.com
